What is Afamitresgene Autoleucel Injection used for?

Last updated September 7, 2026.

Afamitresgene autoleucel (brand name Tecelra) is a one-time engineered T-cell therapy used to treat advanced synovial sarcoma, a rare soft tissue cancer, in adults who have already received chemotherapy. It is used when the cancer cannot be removed with surgery or has spread to other parts of the body. Two lab results decide whether you can receive it: your tumor has to make a protein called MAGE-A4, and your blood has to carry a specific HLA-A*02 tissue type. Your own T cells are collected through apheresis, modified in a lab to target the tumor, and given back to you as a single infusion after a short course of lymphodepleting chemotherapy. It is given only at certified treatment centers, because you need close monitoring for cytokine release syndrome, low blood counts, and infection in the weeks that follow. A sarcoma specialist orders the testing and decides whether this therapy fits your situation.

Find answers about afamitresgene autoleucel injection

Start a free AI doctor consult →

What to do

Related questions

Sources

Pymander is not a replacement for a physician and does not provide medical advice, diagnosis, or treatment.

Free AI doctor, 24/7 by textStart a free AI doctor consult